Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 12:16 AM
NCT ID:
NCT01527058
Eligibility Criteria:
Inclusion Criteria:
* Healthy volunteers:
* Males and females, ≥30 and ≤ 70 years old
* Cancer patients:
* Males and females, ≥30 years old
* CT and/or 18F-FDG PET/CT diagnosis in suspicion of primary or recurrent lung cancer.
* The lung cancer will be histologically confirmed or results of histology will be available.
Exclusion Criteria:
* Females planning to bear a child recently or with childbearing potential
* Renal function: serum creatinine \>3.0 mg/dL (270 μM/L)
* Liver function: any hepatic enzyme level more than 5 times upper limit of normal.
* Known severe allergy or hypersensitivity to IV radiographic contrast.
* Patients not able to enter the bore of the PET/CT scanner.
* Inability to lie still for the entire imaging time because of cough, pain, etc.
* Inability to complete the needed examinations due to severe claustrophobia, radiation phobia, etc.
* Concurrent severe and/or uncontrolled and/or unstable other medical disease that, in the opinion of the Investigator, may significantly interfere with study compliance.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT01527058
Study Brief:
Protocol Section:
NCT01527058